Jia Yali, Hormel Tristan T, Hwang Thomas S, Wu An-Lun, Liang Guangru B, Guo Yukun, Wei Xiang, Ni Shuibin, Jian Yifan, Campbell J Peter, Bailey Steven T, Morrison John C, Huang David
Casey Eye Institute, Oregon Health and Science University, Portland, OR, USA; Department of Biomedical Engineering, Oregon Health and Science University, Portland, OR, USA.
Casey Eye Institute, Oregon Health and Science University, Portland, OR, USA.
Prog Retin Eye Res. 2025 Jul;107:101378. doi: 10.1016/j.preteyeres.2025.101378. Epub 2025 Jun 13.
Optical coherence tomography angiography (OCTA) is a volumetric, non-invasive, high-resolution vascular imaging modality capable of acquiring highly detailed visualizations of retinal microvasculature. It has become an important tool for diagnosis and prognosis in prevalent diseases and pathologies such as diabetic retinopathy, retinopathy of prematurity, and vein occlusions, as well as more rare conditions, including inherited retinal dystrophies. It is also useful for measuring treatment response and assessing which patients would benefit from treatment. Unlike dye-based angiography, OCTA eliminates risks such as anaphylaxis. It also often outperforms fundus photography in feature detection. However, conventional OCTA imaging has been limited by its small field of view, which restricts simultaneous visualization of the posterior pole and peripheral retina, causing single images to potentially miss widely spaced critical biomarkers and pathological features. Recent technological advances in widefield OCTA have addressed this limitation, extending the field of view to the mid-periphery and beyond. This breakthrough enhances the simultaneous detection of macular and peripheral retinal pathology and significantly broadens OCTA's diagnostic and research applications. This review explores the technical innovations enabling widefield OCTA and highlights its clinical utility across various conditions, emphasizing its growing importance as a powerful tool in ophthalmic practice and research.
光学相干断层扫描血管造影(OCTA)是一种容积性、非侵入性、高分辨率的血管成像方式,能够获取视网膜微血管系统的高度详细图像。它已成为糖尿病视网膜病变、早产儿视网膜病变和静脉阻塞等常见疾病及病理状况诊断和预后评估的重要工具,对于包括遗传性视网膜营养不良等更罕见病症也同样适用。它还可用于测量治疗反应以及评估哪些患者将从治疗中获益。与基于染料的血管造影不同,OCTA消除了诸如过敏反应等风险。在特征检测方面,它通常也优于眼底摄影。然而,传统的OCTA成像受其小视野的限制,这限制了后极部和周边视网膜的同时可视化,导致单个图像可能遗漏间隔较远的关键生物标志物和病理特征。宽视野OCTA的最新技术进展解决了这一限制,将视野扩展到中周边及更远处。这一突破增强了黄斑和周边视网膜病变的同时检测能力,并显著拓宽了OCTA的诊断和研究应用范围。本综述探讨了实现宽视野OCTA的技术创新,并强调了其在各种病症中的临床应用价值,突显了其作为眼科实践和研究中一项强大工具日益增长的重要性。